[PDF][PDF] Defining the mechanism of action in a novel class of anti-PD-1 antibodies

V Joo - 2021 - serval.unil.ch
Classical antagonistic antibodies (Abs) targeting PD-1, such as pembrolizumab and
nivolumab, act through blockade of the PD-1–PDL-1 interaction. Here, we have identified …

[PDF][PDF] Defining the mechanism of action in a novel class of anti-PD-1 antibodies

V Joo - 2021 - serval.unil.ch
Classical antagonistic antibodies (Abs) targeting PD-1, such as pembrolizumab and
nivolumab, act through blockade of the PD-1–PDL-1 interaction. Here, we have identified …